Friday, February 26, 2021
wellness India Expo
Home Tags API

Tag: API

Pharma sector revenue to remain healthy at 8-11% in FY-2022: ICRA

Minimal impact of Covid-19 on the Indian pharmaceutical industry owing to inelastic demand for drugs coupled with continued supply of APIs/KSM from China, which accounts for 60% of industry requirement......................

India reports a decline of 17.6% in Malaria cases during 2019

As per the WHO World Malaria Report 2020, India continues to make impressive gains in the reduction of the Malaria burden. The country has sustained Annual Parasitic Incidence (API) of less than one since 2012......................

Govt proactively looking to provide industrial parks with facilities to grow...

The Minister further said that the Government is proactively looking to provide industrial parks with facilities to grow API, pharmaceutical, and nutraceutical industries..................

Are India’s pharma regulations denting patient safety?

Experts shed light on the cause of rising Vitamin C prices and why patients end up paying a higher price for basic affordable vitamins which were otherwise available at reasonable prices earlier......................

Govt to promote high quality drug production, reiterates Navdeep Rinwa at...

The government of India will promote high scale and high-quality drug production’ stated Mr Navdeep Rinwa, IAS, Joint Secretary, Department of Pharmaceuticals Government of India while addressing a video conference organized by PHD Chamber of Commerce and Industry (PHDCCI) on The Future Of Pharma Industry recently................

Thermo Fisher inaugurates world class facility to spur clinical trials market...

The state-of-the-art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built to help address the growing demand for development supply chain services................

Jubilant Life Sciences YoY revenue up by 21% at 9,111 crore

While the company recorded the year on year revenue growth up to 21 percent standing ar Rs 9,111 crore and EBITDA up by 14% to Rs 1,775 crore. The normalized PAT stood at Rs 855 crore. During the fourth quarter, revenue was Rs 2,386 crore and normalized PAT was at Rs 135 Crore................

US-China trade war offers window of opportunity for Indian pharma sector

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

Govt restricts manufacture & sale of Oxytocin in India, bans its...

While the regulations with regard manufacture of Oxytocin for domestic use will come into force on 1st July 2018, the ban on import takes immediate effect..............

Dr Reddy’s Laboratories gets USFDA’s EIR to API plant in Telangana

The US Food and Drug Administration has given an 'establishment inspection report' to the company after inspection of Dr Reddy Laboratories active pharmaceutical ingredients (API) unit at Miryalaguda in Telangana.........